Science Explorer Interactive view Map
Company · Tokyo · Japan

TOA EIYO (Japan)

Research works
48
▼ 20% vs 2013–17
Citations
578
12.1 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: TOA EIYO (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at TOA EIYO (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Oxidative Stress, Medicinal Chemistry, Synthesis, Reactive Oxygen Species, Arrhythmias, Anticancer Agents and Ion Channels.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 5.7×13 topics
  2. Oxidative Stress5▲ 5.4×13 topics
  3. Medicinal Chemistry4▲ 20×6 topics
  4. Synthesis4▲ 12×6 topics
  5. Reactive Oxygen Species3▲ 14×6 topics
  6. Arrhythmias3▲ 50×2 topics
  7. Anticancer Agents3▲ 25×4 topics
  8. Ion Channels3▲ 28×2 topics
  9. Calcium Signaling3▲ 44×2 topics
  10. Cardiac Electrophysiology3▲ 75×1 topic
  11. Long-QT Syndrome3▲ 75×1 topic
  12. Sudden Cardiac Death3▲ 47×2 topics
  13. Hypertension2▲ 14×6 topics
  14. Asymmetric Synthesis2▲ 33×5 topics
  15. Drug Discovery2▲ 12×5 topics
  16. Neuroprotection2▲ 13×4 topics
  17. Heterocyclic Compounds2▲ 28×3 topics
  18. Myocardial Infarction2▲ 16×2 topics
  19. Pharmacology2▲ 13×5 topics
  20. Therapeutic Targets2▲ 19×2 topics
  21. Cardiovascular Disease2▲ 3.8×3 topics
  22. Cardioprotection2▲ 132×1 topic
  23. Ischemia-Reperfusion Injury2▲ 43×1 topic
  24. Tumor Microenvironment2▲ 11×2 topics
  25. Antimicrobial Activity2▲ 20×3 topics
  26. Cell Signaling2▲ 11×4 topics
  27. Guidelines2▲ 7.8×2 topics
  28. Catheter Ablation2▲ 29×2 topics
  29. Adenosine Receptors2▲ 135×1 topic
  30. Antioxidant Activity2▲ 6.0×5 topics
  31. Purinergic Signalling2▲ 135×1 topic
  32. Diabetes2▲ 6.2×3 topics
  33. Angiotensin1▲ 129×1 topic
  34. Anticancer1▲ 14×2 topics
  35. Organocatalysis1▲ 42×2 topics
  36. PET Imaging1▲ 13×2 topics
  37. Pharmacokinetics1▲ 10×2 topics
  38. Renin1▲ 129×1 topic
  39. Rituximab1▲ 17×2 topics
  40. Enantioselective Synthesis1▲ 16×2 topics

Which research topics does TOA EIYO (Japan) publish most on?

By volume in 2022–2025: Atrial Fibrillation Management and Outcomes, Cardiac electrophysiology and arrhythmias and Cardiac Arrhythmias and Treatments.

  1. 1 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  2. 2 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  3. 3 Cardiac Arrhythmias and Treatments Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.1%not open45.9%

World: 28% of research is openly available.

with international co-authors5.6%domestic only94.4%

World: 19% is written across borders.

How has TOA EIYO (Japan)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.